2020 ACCP Virtual Journal Club June | Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval-An Analysis of ECGs From the IQ-CSRC Study-On Demand
Evaluation of the Effect of QT-Positive Drugs on the JTpeak Interval-An Analysis of ECGs From the IQ-CSRC Study- On Demand
ACCP Virtual Journal Club Webinars
Live Session: Wednesday, June 17, 2020 from 2:00-3:00 PM ET
On Demand: June 17, 2020 to June 17, 2023
See Handouts tab for Continuing Education information on IPCE credits.
Gilbert J. Burckart, PharmD
Associate Director for Pediatrics
Dr. Gilbert Burckart is presently Associate Director for Pediatrics, Office of Clinical Pharmacology at the US Food & Drug Administration (FDA). Prior to coming to the FDA, Dr. Burckart served on the faculties of four Univs (Buffalo, Tennessee, Pittsburgh and Southern California) as a Professor of Pharmacy, Pediatrics and Surgery for 33 yrs. In the past, Dr. Burckart has served as President of the American Coll of Clinical Pharmacy and President of the American Coll of Clinical Pharmacology®. He moved to the FDA in 2008 where his duties include regulatory science and educational programs in Pediatric Clinical Pharmacology within the Office of Clinical Pharmacology and participation in the FDA’s Pediatric Review Committee.
|Access Date||Quiz Result||Score||Actions|